CUTANEOUS LEISHMANIASIS

CUTANEOUS LEISHMANIASIS was reported 253 times

These drug classes are most commonly taken by patients reporting CUTANEOUS LEISHMANIASIS:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 115
1 Folate Analog Metabolic Inhibitor [EPC] 78
2 Corticosteroid [EPC] 76
3 Purine Antimetabolite [EPC] 21
4 Calcineurin Inhibitor Immunosuppressant [EPC] 7
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5
6 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5
7 Interleukin-12 Antagonist [EPC] 5
8 Interleukin-23 Antagonist [EPC] 5
9 Lipid-based Polyene Antifungal [EPC] 5
10 Polyene Antifungal [EPC] 5
11 Antirheumatic Agent [EPC] 4
12 Azole Antifungal [EPC] 4
13 Aminosalicylate [EPC] 3
14 Antimetabolite Immunosuppressant [EPC] 3
15 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
16 Phosphodiesterase 4 Inhibitor [EPC] 3
17 Retinoid [EPC] 3
18 Tetracycline-class Drug [EPC] 3
19 Xanthine Oxidase Inhibitor [EPC] 3
20 Immunoglobulin G [EPC] 2
21 Penem Antibacterial [EPC] 2
22 Rifamycin Antibacterial [EPC] 2
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2
24 5-alpha Reductase Inhibitor [EPC] 1
25 Aminoglycoside Antibacterial [EPC] 1
26 Angiotensin Converting Enzyme Inhibitor [EPC] 1
27 Anti-epileptic Agent [EPC] 1
28 Catecholamine [EPC] 1
29 Fluoroquinolone Antibacterial [EPC] 1
30 HMG-CoA Reductase Inhibitor [EPC] 1
31 Insulin Analog [EPC] 1
32 Integrin Receptor Antagonist [EPC] 1
33 Kinase Inhibitor [EPC] 1
34 Nitroimidazole Antimicrobial [EPC] 1
35 Nonsteroidal Anti-inflammatory Drug [EPC] 1
36 Platelet Aggregation Inhibitor [EPC] 1
37 Proton Pump Inhibitor [EPC] 1
38 Selective T Cell Costimulation Modulator [EPC] 1
39 Sulfone [EPC] 1
40 Vitamin B12 [EPC] 1
41 Vitamin C [EPC] 1
42 Vitamin D [EPC] 1
43 beta-Adrenergic Blocker [EPC] 1